BEAUPHAR
Absorbed by JM Capital
Part of the group
JM CAPITAL
11 companies
Group, risk and exposure
Holdings and subsidiaries
2 holdingsHoldings 2
Source for every holding own accounts 2025
- APOTHEEK DU FAUXsubsidiaryEquity €545,131 Profit of €121,732 in 2025 (profit of €88,959 in 2024) Checked score 87100%
- APOTHEEK DU FAUX - MERELBEKEsubsidiaryEquity €149,416 Profit of €134,567 in 2025 (profit of €174,921 in 2024) Checked score 85100%
Acquisitions and mergers
1 transactionTaken over by:JM Capital
Connections & network
1 current directorThe network starts from the directors of BEAUPHAR. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.